Exploring the Molecular Mechanism of Cinnamaldehyde Intervening in Ochratoxin A-Induced Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Comorbidity: An Integrated Approach Based on Network Pharmacology, Network Toxicology and Molecular Docking

Mingli Shen, Qingping Shi, Shuang Gao, Beiyan Chen, Jieru Han

Open source

DOI
10.3390/ph19081283
Published
2026-08-13
Container
Pharmaceuticals
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19081283,
  title = {Exploring the Molecular Mechanism of Cinnamaldehyde Intervening in Ochratoxin A-Induced Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Comorbidity: An Integrated Approach Based on Network Pharmacology, Network Toxicology and Molecular Docking},
  author = {Mingli Shen and Qingping Shi and Shuang Gao and Beiyan Chen and Jieru Han},
  year = {2026},
  journal = {Pharmaceuticals},
  doi = {10.3390/ph19081283},
  url = {https://doi.org/10.3390/ph19081283}
}

RIS

TY  - JOUR
TI  - Exploring the Molecular Mechanism of Cinnamaldehyde Intervening in Ochratoxin A-Induced Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Comorbidity: An Integrated Approach Based on Network Pharmacology, Network Toxicology and Molecular Docking
AU  - Mingli Shen
AU  - Qingping Shi
AU  - Shuang Gao
AU  - Beiyan Chen
AU  - Jieru Han
PY  - 2026
JO  - Pharmaceuticals
DO  - 10.3390/ph19081283
UR  - https://doi.org/10.3390/ph19081283
ER  - 

APA

Shen, M., Shi, Q., Gao, S., Chen, B., & Han, J. (2026). Exploring the Molecular Mechanism of Cinnamaldehyde Intervening in Ochratoxin A-Induced Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Comorbidity: An Integrated Approach Based on Network Pharmacology, Network Toxicology and Molecular Docking. Pharmaceuticals. https://doi.org/10.3390/ph19081283

Source records